Literature DB >> 18477905

Type B lactic acidosis and insulin-resistant hyperglycemia in an adolescent following cardiac surgery.

Kourosh Parsapour1, Rama Pullela, Gary Raff, Robert Pretzlaff.   

Abstract

OBJECTIVE: To report the presence of type B lactic acidosis and insulin-resistant hyperglycemia following cardiopulmonary bypass in a pediatric patient.
DESIGN: Case report.
SETTING: Tertiary referral children's hospital pediatric intensive care unit. PATIENT: Fourteen-year-old child with hyperlactatemia and hyperglycemia following cardiac surgery. INTERVENTIONS AND
RESULTS: We report a patient who following cardiopulmonary bypass for repair of his congenital heart disease developed type B lactic acidosis and hyperglycemia resistant to insulin therapy. Resolution of his hyperlactatemia and hyperglycemia occurred approximately 24 hrs postoperatively without apparent ill effect.
CONCLUSIONS: Type B lactic acidosis is a phenomenon that may occur in the pediatric population in conjunction with insulin-resistant hyperglycemia. We observed that its resolution corresponded to improvement in the patient's hyperglycemia.

Entities:  

Mesh:

Year:  2008        PMID: 18477905     DOI: 10.1097/01.PCC.0000298767.20400.66

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  2 in total

1.  Lactate clearance as a prognostic marker of mortality in severely ill febrile children in East Africa.

Authors:  A Aramburo; Jim Todd; Elizabeth C George; Sarah Kiguli; Peter Olupot-Olupot; Robert O Opoka; Charles Engoru; Samuel O Akech; Richard Nyeko; George Mtove; Diana M Gibb; Abdel G Babiker; Kathryn Maitland
Journal:  BMC Med       Date:  2018-03-09       Impact factor: 8.775

2.  Assessing the incidence of acidosis in patients receiving metformin with and without risk factors for lactic acidosis.

Authors:  Katy E Trinkley; Heather D Anderson; Kavita V Nair; Daniel C Malone; Joseph J Saseen
Journal:  Ther Adv Chronic Dis       Date:  2018-06-13       Impact factor: 5.091

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.